The sAUC of AFP, respectively PIVKA II for the discrimination between patients with HCC and those without, were 0.808 (95% CI 0.782 to 0.834) vs. 0.851 (95% CI 0.823 to 0.878)-data were reported in Figure 2. Here, AFP is linked to hepatocellular carcinoma.